The short answer
You cannot sell a prescription as a Shopify cart item, and you do not need to. The pattern that works is a clinical storefront on a subdomain or path of your domain, with your brand, that takes a customer from a quiz or a product page into medical intake, routes the case to a licensed provider in the customer's state, captures payment only when the provider approves, ships the prescription from a pharmacy, and manages refills in a patient portal. Shopify keeps selling supplements; the clinical storefront sells the program; the two share a brand, a domain and, within limits described below, a customer.
The evidence that this is worth doing comes from a Fuse Health case study published May 6, 2026: a supplement brand with $4 million in annual revenue launched a GLP-1 program in five weeks, staged peptides for the following quarter, ran the first cohort "profitable without paid spend" on cross-sell alone, and within 90 days had "monthly recurring revenue that exceeded any single supplement product's monthly performance." The numbers are the vendor's; the shape matches what we see, and the reason is the acquisition line. A telehealth brand starting from zero pays $150 to $400 to acquire a patient and often fails to. A supplement brand has already paid that, and the customer is on its email list.
Why it runs beside Shopify
Three reasons, in order of how often they surprise founders. Shopify's policies restrict the sale of prescription drugs through its checkout, so the prescription can never be a SKU with a price in the cart. A prescription requires a clinical decision between the click and the charge, which a cart does not model: the customer may be declined, may need a different dose, or may need labs first. And the moment a customer answers a medical question, the data is protected health information under HIPAA, which your Shopify store, your Klaviyo account and your Meta pixel are not set up to hold.
So the clinical storefront is a separate system with its own consent, its own data handling and its own billing logic, connected to Shopify at the edges: the customer arrives from your site, the brand is yours, and the outcomes you need for marketing come back as events without the medical content attached. We covered the mechanics of that connection in connecting Shopify-style e-commerce with GLP-1 clinical workflows, and why some upsells belong in the portal rather than the Shopify checkout explains the reverse direction.
The architecture
| Layer | Stays in Shopify | Moves to the clinical storefront |
|---|---|---|
| Discovery | Product pages, blog, quiz widget, email and SMS campaigns | The eligibility check inside the quiz, once it asks a medical question |
| Identity | Customer account for supplements | Patient account with identity verification, consents, state of residence |
| Commerce | Supplement cart, subscriptions for supplements | Program membership, authorized at checkout, captured on provider approval; drug billed transparently |
| Fulfilment | Your 3PL | Pharmacy routing with tracking visible to the patient |
| Retention | Klaviyo or Customer.io flows for supplement customers | Portal messaging, refill automation, dose changes, side-effect triage |
| Data | Orders, emails, marketing consent | The medical record, held by the clinical entity, with the platform as business associate |
The line between the two identity rows is the one to get right. A supplement customer who clicks "see if you qualify" is still a customer until the first medical question; after it, they are a patient, and the record lives in the clinical system. Marketing can know that a customer converted to a program (an event) and can receive the patient's marketing preferences; it must not receive the answers, the diagnosis or the drug. Meta and Snap pixels on the clinical storefront's intake and checkout pages are what the FTC's July 29 complaint against Hims & Hers is about, and the fix is described in the checkout spec.
Programs by brand type
| Brand type | First program | Why it fits | Price signals (2026) |
|---|---|---|---|
| Weight and metabolic supplements | Branded GLP-1 care membership; maintenance program for customers at goal | The customer is already buying protein, fiber and electrolytes for the same goal; the reverse cross-sell (GLP-1 patients need those products) is the second revenue line | $99 to $149 membership; drug at manufacturer price ($149 Wegovy pill starting dose) |
| Men's performance and grooming | Hair loss (finasteride, minoxidil); sexual health; TRT with labs | High-frequency, high-retention prescriptions with a familiar brand voice | $25 to $90 hair; $100 to $200 TRT bundles |
| Women's wellness | Menopause and hormone programs; sexual health | Wheel reports patients 43 and older are now more than four in ten telehealth visits; the customer base is already there | $100 to $200 with labs |
| Longevity and biohacking | NAD+, sermorelin, labs-first membership; peptides as the FDA list allows | The audience asks for these by name; the legal set is smaller than the wish list | $150 to $300 membership |
| Sleep and stress | Sleep programs, and OSA screening where Zepbound's indication applies | Adjacent to existing SKUs; lower regulatory load | $49 to $149 |
The treatments directory lists what Turbopills can configure by program; the specialty expansion post is the sequencing logic. Our opinion for a weight brand: start with the branded GLP-1 membership and the maintenance program together, because half the customers who ask about GLP-1s have already been on one and stopped.
The compliance spine
Supplement brands live under DSHEA's structure-and-function rules; prescription programs live under drug-marketing rules, and the two cannot share copy. The product page that says a supplement "supports metabolic health" cannot sit next to a program page that implies the supplement treats obesity, and neither can imply the prescription program cures anything. FDA's warning letters to telehealth marketers in March and June 2026 cited "clinically proven" and "FDA approved" language on programs that could not support it. Keep the clinical storefront's copy to what the drug's label and your clinical protocol support, and keep the supplement copy where it was.
Three more items. LegitScript certification for the clinical domain before any Meta or Google ads for the program ($975 to apply, $2,150 a year; the LegitScript post). A clinical entity: the brand's owners are not clinicians, so a physician-owned professional corporation and a management agreement, explained in the MSO and friendly-PC post, or a platform's provider network routed to a structure your counsel approves. And payment processing approval for the program, separate from the supplement store's account, because Stripe treats telemedicine as a restricted category and your dispute ratio for the program should not be pooled with your supplement orders.
The five-week plan
Fuse's case study is the benchmark for the calendar, and five weeks is achievable only because the brand already has the audience, the domain and the trust. Week one: entity and medical director, LegitScript filed, program and pricing decided, pharmacy chosen. Week two: clinical storefront configured under the brand, quiz widget on the Shopify site, intake and protocols loaded, consent language reviewed. Week three: billing on the brand's own gateway with capture-on-approval, portal and refill automation, email flows for the customer-to-patient handoff, pixels removed from clinical pages. Week four: test end to end with staff as patients, including a declined case and a failed payment; brief support. Week five: launch to the email list, one segment at a time, with the maintenance program offered to past GLP-1 users first.
Turbopills ships the clinical side of that plan as one configured system, storefront, conditional intake, state-aware provider routing, approval-gated billing, pharmacy routing and portal, with a Shopify integration and embeddable smart widgets for the quiz. We are in private beta and quote per program; the demo to ask for is the customer-to-patient handoff, because that is where a supplement brand's launch succeeds or leaks.
The cross-sell math
A brand with 40,000 customers on its list and 2% conversion to a $149 program has 800 patients and about $119,000 of monthly program revenue, at close to zero acquisition cost. By the margin model, a program that size on a flat-fee platform keeps roughly three quarters of that as contribution, and the retention job is easier than a standalone brand's because the patient already receives your emails and buys your products. The reverse line is real too: GLP-1 patients buy protein, fiber, electrolytes and skin products at higher rates than the average customer, which is why GLP-1 nutrition support belongs in the program design and not only in the store.
FAQ
Can I sell prescription products on Shopify? Not through the Shopify cart. Prescription programs run on a clinical storefront beside the Shopify store, under the same brand, with medical intake, provider review, approval-gated billing and pharmacy fulfilment. Supplements stay in Shopify.
How do supplement brands add telehealth? By adding a clinical storefront and a licensed clinical entity: a quiz on the store leads into medical intake, a licensed provider in the customer's state reviews the case, payment is captured on approval, a pharmacy ships the prescription, and a portal handles refills. Vendors report launches in about five weeks for brands with an existing audience.
Will telehealth prescribe GLP-1s for my supplement customers? A licensed provider will evaluate each customer and prescribe where clinically appropriate; the brand cannot promise a prescription. Branded GLP-1s are available at manufacturer cash prices, and a maintenance program serves customers who have already stopped a GLP-1.
What are examples of wellness brands with prescription programs? The Vitamin Shoppe's Whole Health Rx service (with WellSync) is a retail example; Fuse Health published a case study of a $4 million supplement brand adding a GLP-1 program in 2026; creator-led brands are launching hormone and peptide clinics on the same model. Hims & Hers itself began as a consumer brand before becoming a telehealth company.
Can my Klaviyo flows include patients? Marketing tools can know that a customer enrolled and can hold marketing preferences; they must not hold intake answers, diagnoses or prescriptions. Patient communications about care run from the clinical system under its consent, and advertising pixels stay off intake and checkout pages.